PRNewsWire - Health

HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH)
Kelun-Biotech Announces Approximately US$250 Million Placement
Major Fitness Unveils Sleeker, Stronger Online Home: Welcome to MajorFitness.com!